Identified General Payments to Physicians and a primary specialty of ophthalmology. Basic statistical analysis was performed including mean, median, and range of payments for both single payments and per provider.
As a part of the Affordable Care Act of 2010, a provision known as the Physician Payments Sunshine Act was established to provide greater transparency of physician and hospital relationships with industry. 1 As many as 94% of United States physicians have relationships with industry through research, consulting, medical education, and gifts. 2, 3 However, patients tend to be unaware about their physicians' financial ties, although they generally believe that such ties should be disclosed. 2 Under the law, any payments or transfer of value, which may include cash, gifts, services, or stock to a licensed physician must be reported if the payment was made by a drug or device manufacturer who manufactures a product covered by a government-sponsored health program. 1 This includes payments for consulting, gifts, food, travel, education, grants, research, ownership, licenses, royalties, speaker honoraria, and charitable contributions. Small payments of less than $10 are not reported unless in aggregate the payments exceed $100 in a calendar year. 1 Sample medications, educational materials for patients, trial loans of devices, discounts, rebates, and dividends need not be reported. 1 On September 30, 2014, the database was released publicly in several formats including a website, an online database, and downloadable files. 4 General payment details, research payment details, and physician ownership details each were released along with identified and de-identified information. The purpose of this evaluation was to review the identified general payments data to determine the characteristics of payments to providers with a primary specialty identified as ophthalmology and to compare these with those of several other surgical subspecialties.
Methods
The study was a retrospective analysis using the Centers for Medicare and Medicaid Services Open Payments website and data based on primary physician specialty. 4 Each data point included a single payment in United States dollars to a single physician by an entity. The primary taxonomy specialties of dermatology, neurosurgery, orthopedics, and urology were selected for comparison with ophthalmology. If several taxonomies applied to the specialty, then these were evaluated in aggregate (for example, dermatology included those with specialty of dermatology, dermatology Mohs surgery, and procedural dermatology Each payment had the option to be recorded with data regarding the company and covered drug or biological or medical device. The entries were divided into the following categories: ophthalmic medication, ophthalmic surgical devices, ophthalmic diagnostic instrument, ophthalmic miscellaneous, systemic therapy, and category not available. If no product or device was noted, then the author decided the nature of the company based on their clinical care products. In some cases, the companies or organizations specialize in primarily ophthalmic medications, devices, and instruments and were placed in these categories. In other cases, the companies or organizations had diverse product lines in multiple ophthalmic or medical specialties and it was not possible to derive the category. In the case of systemic medications that may be used in multiple diseases, but also in ophthalmology, the therapy was considered to fall into the category of systemic therapy.
The de-identified data were not downloaded because of file size and lack of additional demographic information. In addition, deidentified data included contested entries. Data were limited only to the general payments dataset.
Results
For physicians with primary specialty of ophthalmology, a total of 55 996 individual payments were recorded from August 1, 2013, through December 31, 2013. None of the payments reported in this database were marked as disputed. The total amount of payments reported was $10 926 447. The mean payment amount was $195.13 (range, $0.04e$193 073), and a distribution of payment amounts by dollar range is noted in Table 1 .
A total of 9855 unique physician profile identifiers received payments, an average of 5.7 payments per physician identifier. The average received per physician identifier was $1108 (range, $1e$397 849), with a median of $112.01. Table 2 summarizes the distribution of payments by dollar range per provider identifier.
The following categories were supplied for the nature of payment classification: charitable contribution; compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program; compensation for serving as faculty or as a speaker for an accredited or certified continuing education program; consulting fee; current or prospective ownership or investment interest; education; entertainment; food and beverage; gift; grant; honoraria; royalty or license; and travel and lodging. The distributions across these categories are represented in Table 3 . The greatest percentage went to consulting fees, followed by compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program, food and beverage, and travel and lodging. The largest single amount received was in the category of royalty or license, for an amount of $193 073. The greatest number of payments was in the food and beverage category: 9479. Figure 1 summarizes the payments by geographic region, with the highest dollar amount going to physicians in the South, followed by the Midwest, Northeast, and West. When evaluating average payment per provider in each geographic region, the average was $1479 in the Midwest, $1065 in the Northeast, $1030 in the West, and $935 in the South. One payment of $197 was assigned to a provider with no listed address. A summary of payments by medication and device type is summarized in Figure 2 , with the greatest dollars in the category of ophthalmic medications, followed by ophthalmic miscellaneous and ophthalmic surgery. Table 4 compares the payments in ophthalmology with those in dermatology, neurosurgery, orthopedics, and urology by total dollars, with a mean, median, and range of dollars per provider identification. The mean payment per physician in these specialties ranged from $954 to $6980, and the median payment per physician ranged from $88 to $173. 
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Discussion
The Physician Payments Sunshine Act has provided a large amount of data previously unavailable for the purpose of providing transparency in medical care. However, this sizeable database is unmanageable for most people because the overall data file exceeds sizes that can be downloaded simply or managed in popular commercial programs like Microsoft Excel. The easiest way to view these data is in portions at a time, as in this analysis.
Because of the enormity of the database and the configuration of the online tools, the easiest way to find information is to search for an individual provider. Retrieving individual numbers does not provide context of behavior, and so one purpose of this report was to provide contextual information. The results allow for greater comparison and understanding of the details in payments to ophthalmologists and to see if this differed greatly from other surgical subspecialties. From this analysis, 20.3% of the individual payments to ophthalmologists were listed as $10 or less and 72.6% of the payments were $50 or less, suggesting that most of the individual payments were relatively small. Less than $500 total was received by 88% of the physician identifiers reported in the field because the largest expenditures went to a small group of physicians. More than 86% of the individual payments were categorized as food and beverage; however, the total spending in this category made up only 15% of the overall spending. The travel and lodging category consisted of 11% of the spending. The results are consistent with the survey reported by Campbell et al 3 of other subspecialties, where sponsored food was the most common industry relationship reported by physicians. In their systematic review of patient opinions, Licurse et al 2 found that payments for food and trips were the most unfavorably viewed. Grande et al 5 reported that inexpensive promotional items had some effect on medical school students' opinions of statin medications for hypercholesterolemia, and perhaps although the vast majority of expenditures are small, they may also affect opinions of physicians. Another survey of pharmaceutical gifts noted that patients tend to view pharmaceutical gifts more negatively than physicians did. 6 Consulting fees (42%) made up the largest category of expenditures, likely because the average consulting fee was much higher than the average payment ($3313 vs. $195.13). Although consulting payments made up the bulk of the spending, patients have a more favorable view of their physicians receiving these payments. 7, 8 In those studies, the authors suggested that patients may believe a physician who is a consultant is most up to date with information, influential, or a key opinion leader. 7, 8 From a business standpoint, investing in physicians with a reputation for being key opinion leaders has greater return, likely explaining the higher fees for this segment as well as in the speaker categories.
Some of the categories may overlap because it may be difficult to differentiate between a consultant physician who gives a presentation as consulting, education, or services other than consulting, including serving as a faculty or speaker. Each category may have a different public stigma. Because each category had a sizeable dollar allocation, it is unlikely that there is misrepresentation in these categories. Only 2 entries were noted for the category of faculty or speaker at an accredited or certified continuing education program. This may be because of changing regulations regarding industry sponsorship for education programs. Many education programs are run by third parties that may or may not have industry relationships, and the spending for these is not disclosed in this report because they are not necessarily related to a single product. There did not seem to be large variations by geography. Although the sum of dollars was spent in the South, on a per-physician basis, it was higher in the Midwest and lowest in the South. Higher spending in the South than in other regions is most likely because 2 of the largest single payments ($193 072.68 and $187 987.68 in the category of royalty or license) were in the South. A state law restricting physicians from accepting meals in Massachusetts was in effect from 2010 through 2012. Only 8% of dollars in this state went to the food and beverage category as opposed to 15% nationally, suggesting there may be a lingering effect from this legislation.
Compared with other surgical subspecialties, there was not a large difference in the median amount the physician in each specialty seems to have received. Although the mean amounts varied somewhat, this seems to be an effect from the highest sums received. In general, the range at the upper end has greater variance, and this may be related to medical devices and royalty payments.
Most of the dollars came from companies associated with ophthalmic medications and surgical and diagnostic equipment, with medications making up the largest share. This is probably because the medications have the greatest audience within the ophthalmology group, whereas surgical equipment can vary between subspecialties. Of note, sample medications and instruments are not included and may affect physician choices. 9, 10 By extension, sample surgical instruments allow a surgeon to gain familiarity, thus influencing future purchases. A counterargument is that sample medications do benefit patients with limited insurance or pharmaceutical coverage. 11, 12 The impact of this information on public perception is unknown. Generally speaking, patient understanding of physician compensation is poor. 13 Perhaps some may interpret receiving money from industry as beneficial and do not mind if their physician is involved in innovation or consulting, 7, 8 whereas others may interpret this as undue influence. 2 Grady et al 14 demonstrated that a percentage of their patient cohort believed that the payments physicians received were a private matter. Some patients want full disclosure of financial relationships, 15 although others have reported in studies that they would still participate in research regardless of the involvement of their doctors in industry. 7, 8, 16 In a contrasting study, Kim et al 17 found that 64% to 87% of subjects in a research trial wanted to know the financial influences of the researchers.
Other areas where industry has influence, such as directto-consumer marketing and advertising to nonphysicians (departmental managers or staff), are not reflected in this report, and their relative impact on costs and decision making is unknown. Sponsorships of local and national meetings and drug reimbursement programs are not included in these costs and are likely influential. Resident physicians are excluded from the report and this may be important because targeting younger physicians may be more effective as their practice patterns are still relatively malleable. 10 Other authors have even suggested that this spending and influence may be beneficial and should be increased. 18 Disclosure of financial relationships improved patient loyalty to physicians in one study: fewer than 5% of patients felt less loyal to their physicians after financial disclosure information was provided. 19 Limitations to the analysis include the short period from August through December 2013, so it is not known if this can be extrapolated to full-year data. The database is dependent on the vendors for their entry and accuracy. Physicians had the opportunity to dispute claims; however, this system encountered errors and may not have been used fully by each physician. Investment income or ownership in a company was not reported in this particular database. Geographic data were based on physician's listed mailing address, and it is unclear if bundled payments to a group were attributed to individuals. These data are for only 1 time point, so no information regarding trends over time can be assessed as of yet.
As our society moves toward more open disclosures, the availability of data may prove beneficial. At this time, it remains to be seen how this information will affect the ever-present relationships among physicians, patients, and industry. 
